Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, August 11, 2023
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
Edward Tenthoff Maintained (APTO) at Buy with Decreased Target to $12 on, Aug 11th, 2023
Edward Tenthoff of Piper Sandler, Maintained "Aptose Biosciences Inc." (APTO) at Buy with Decreased Target from $37 to $12 on, Aug 11th, 2023.
Edward has made no other calls on APTO in the last 4 months.
There is 1 other peer that has a rating on APTO. Out of the 1 peers that are also analyzing APTO, 0 agree with Edward's Rating of Hold.
This is the rating of the analyst that currently disagrees with Edward
- Li Watsek of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $38 on, Monday, June 12th, 2023
